www.praktickelekarenstvi.cz e11 PRAKTICKÉ LÉKÁRENSTVÍ AKTUÁLNÍ FARMAKOTERAPIE Farmakoterapie během kardiopulmonální resuscitace diac arrest due to asystole and pulseless electrical activity. Circ J 2011; 75: 580–588. 54. Marshall RS. Progress in intravenous thrombolytic therapy for acute stroke. JAMA Neurol 2015; 72: 928–934. 55. Solhpour A, Yusuf SW. Fibrinolytic therapy in patients with ST-elevation myocardial infarction. Expert Rev Cardiovasc Ther 2014; 12: 201–215. 56. Marti C, John G. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 2015; 36: 605–614. 57. Fischer M, Böttiger BW, Popov-Cenic S, Hossmann KA. Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat. Intensive Care Med 1996; 22: 1214–1223. 58. Böttiger BW, Bode C, Kern S, Gries A, Gust R, Glätzer R, Bauer H, Motsch J, Martin E. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet 2001; 357: 1583–1585. 59. Fatovich DM, Dobb GJ, Clugston RA. A pilot randomised trial of thrombolysis in cardiac arrest (The TICA trial). Resuscitation 2004; 61: 309–313. 60. Abu-Laban RB, Christenson JM, Innes GD, van Beek CA, Wanger KP, McKnight RD, MacPhail IA, Puskaric J, Sadowski RP, Singer J, Schechter MT, Wood VM. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med 2002; 346: 1522–1528. 61. Böttiger BW, Arntz HR, Chamberlain DA, Bluhmki E, Belmans A, Danays T, Carli PA, Adgey JA, Bode C, Wenzel V, Chamberlain DA. Thrombolysis during resuscitation for out-of- -hospital cardiac arrest. N Engl J Med 2008; 359: 2651–2662. 62. Bozeman WP, Kleiner DM, Ferguson KL. Empiric Tenecteplase is associated with increased return of spontaneous circulation and short term survival in cardiac arrest patients unresponsive to standard interventions. Resuscitation 2006; 69: 399–406. 63. Kraut JA, Madias NE. Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol 2010; 6: 274–285. 64. Federiuk CS, Sanders AB, Kern KB, Nelson J, Ewy GA. The effect of bicarbonate on resuscitation from cardiac arrest. Ann Emerg Med 1991; 20: 1173–1177. 65. Dybvik T, Strand T, Steen PA. Buffer therapy during out-of-hospital cardiopulmonary resuscitation. Resuscitation 1995; 29: 89–95. 66. Weng YM, Wu SH, Li WC, Kuo CW, Chen SY, Chen JC. The effects of sodium bicarbonate during prolonged cardiopulmonary resuscitation. Am J Emerg Med 2013; 31: 562–565. 67. Raymond TT, Zaritsky AL, Nadkarni V, Bembea M, Fink E, Gaies MG, Guerguerian AM, Parshuram C, Knight L, Kleinman M, Laussen PC, Schexnayder SM, Sutton R, Topjian AA. Sodium bicarbonate use during in-hospital pediatric pulseless cardiac arrest – a report from the American Heart Association Get With The Guidelines((R))-Resuscitation. Resuscitation 2015; 89: 106–113. 68. Olasveengen TM, Sunde K, Brunborg C, Thowsen J, Steen PA, Wik L. Intravenous drug administration during out-of-hospital cardiac arrest: a randomized trial. JAMA. 2009.
RkJQdWJsaXNoZXIy NDA4Mjc=